Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Cancer Research and Clinical Oncology|October 21, 2021
Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasmsSamantha O'Hagan Henderson, Jochen J Frietsch, Inken Hilgendorf, et al.Journal of Cancer Research and Clinical Oncology|December 17, 2022
Psychosocial distress in young adults surviving hematological malignancies: a pilot studyAndreas Wittwer, Kristin Sponholz, Jochen J Frietsch, et al.Cytometry. Part B, Clinical Cytometry|April 12, 2013
Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses trackUlf Schnetzke, Mike Fischer, Jochen J Frietsch, et al.Bone Marrow Transplantation|July 2, 2020
Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensityJochen J Frietsch, Friederike Hunstig, Christoph Wittke, et al.Infection|January 3, 2023
Isolation of Hafnia paralvei co-harbouring blaNDM-1 and blaVIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantationTobias Manuel Appel, Claudia Stein, Christian Brandt, et al.Bone Marrow Transplantation|May 10, 2022
Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphomaJochen J Frietsch, Jenny Miethke, Paul Linke, et al.Mediterranean Journal of Hematology and Infectious Diseases|January 24, 2019
In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell TransplantationJochen J Frietsch, Detlef Michel, Thomas Stamminger, et al.European Journal of Haematology|March 19, 2014
Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature reviewJochen J Frietsch, Sebastian Dornaus, Thomas Neumann, et al.Journal of Cancer Research and Clinical Oncology|January 31, 2022
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemiaMaximilian Fleischmann, Sebastian Scholl, Jochen J Frietsch, et al.Leukemia|March 28, 2020
SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disordersAlexander Kaiser, Martin Schmidt, Otmar Huber, et al.Pageof 3